Chargement en cours...
Radiosensitization by the investigational NEDD8-activating enzyme inhibitor MLN4924 (pevonedistat) in hormone-resistant prostate cancer cells
Salvage radiotherapy (SRT) is the first-line treatment for prostate cancer patients with biochemical recurrence following radical prostatectomy, and new specific radiosensitizers are in urgent need to enhance SRT effect. MLN4924 (also known as Pevonedistat), a specific inhibitor of NEDD8-activating...
Enregistré dans:
Publié dans: | Oncotarget |
---|---|
Auteurs principaux: | , , , , , , , , , , , , , |
Format: | Artigo |
Langue: | Inglês |
Publié: |
Impact Journals LLC
2016
|
Sujets: | |
Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5122397/ https://ncbi.nlm.nih.gov/pubmed/27224919 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9526 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|